Phase 2a Study for PK/PD of nC-001

NCT06798675 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

CHRONIC HYPONATREMIA

Interventions

DRUG: nC-001
DRUG: Placebo

Sponsor

nephCentric